These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 10101030)

  • 1. Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation.
    Henry EC; Kende AS; Rucci G; Totleben MJ; Willey JJ; Dertinger SD; Pollenz RS; Jones JP; Gasiewicz TA
    Mol Pharmacol; 1999 Apr; 55(4):716-25. PubMed ID: 10101030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds.
    Gasiewicz TA; Kende AS; Rucci G; Whitney B; Willey JJ
    Biochem Pharmacol; 1996 Dec; 52(11):1787-803. PubMed ID: 8986142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-specific transcriptional activity of synthetic flavonoids in guinea pig and mouse cells as a result of differential activation of the aryl hydrocarbon receptor to interact with dioxin-responsive elements.
    Zhou JG; Henry EC; Palermo CM; Dertinger SD; Gasiewicz TA
    Mol Pharmacol; 2003 Apr; 63(4):915-24. PubMed ID: 12644593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 4 S [3H]beta-naphthoflavone-binding protein in liver cytosol of female Sprague-Dawley rats treated with aryl hydrocarbon receptor agonists.
    Brauze D; Malejka-Giganti D
    Biochem J; 2000 May; 347 Pt 3(Pt 3):787-95. PubMed ID: 10769184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells.
    Lu YF; Santostefano M; Cunningham BD; Threadgill MD; Safe S
    Arch Biochem Biophys; 1995 Jan; 316(1):470-7. PubMed ID: 7840652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibit sustained depletion of aryl hydrocarbon receptor protein in liver, spleen, thymus, and lung.
    Pollenz RS; Santostefano MJ; Klett E; Richardson VM; Necela B; Birnbaum LS
    Toxicol Sci; 1998 Apr; 42(2):117-28. PubMed ID: 9579024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-methoxy-4'-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism.
    Zhou J; Gasiewicz TA
    Arch Biochem Biophys; 2003 Aug; 416(1):68-80. PubMed ID: 12859983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy.
    Pollenz RS; Sattler CA; Poland A
    Mol Pharmacol; 1994 Mar; 45(3):428-38. PubMed ID: 8145729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
    Son DS; Rozman KK
    Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chelatable metal ions are not required for aryl hydrocarbon receptor transformation to a DNA binding form: phenanthrolines are possible competitive antagonists of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Mahon MJ; Gasiewicz TA
    Arch Biochem Biophys; 1992 Aug; 297(1):1-8. PubMed ID: 1322109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists.
    Lu YF; Santostefano M; Cunningham BD; Threadgill MD; Safe S
    Biochem Pharmacol; 1996 Apr; 51(8):1077-87. PubMed ID: 8866830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding and transcriptional enhancement by purified TCDD.Ah receptor complex.
    Henry EC; Kent TA; Gasiewicz TA
    Arch Biochem Biophys; 1997 Mar; 339(2):305-14. PubMed ID: 9056263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist but not antagonist ligands induce conformational change in the mouse aryl hydrocarbon receptor as detected by partial proteolysis.
    Henry EC; Gasiewicz TA
    Mol Pharmacol; 2003 Feb; 63(2):392-400. PubMed ID: 12527811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Pollenz RS
    Mol Pharmacol; 1996 Mar; 49(3):391-8. PubMed ID: 8643077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor.
    Gasiewicz TA; Rucci G
    Mol Pharmacol; 1991 Nov; 40(5):607-12. PubMed ID: 1658599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction.
    Mukai R; Shirai Y; Saito N; Fukuda I; Nishiumi S; Yoshida K; Ashida H
    Arch Biochem Biophys; 2010 Sep; 501(1):134-41. PubMed ID: 20450880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.
    Backlund M; Ingelman-Sundberg M
    Mol Pharmacol; 2004 Feb; 65(2):416-25. PubMed ID: 14742684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.